Surgically Treated pT2aN0M0 (Stage IB) Non-Small Cell Lung Cancer: A 20-Year Single-Center Retrospective Study

Introduction The suitability of adjuvant therapy (AT) in patients with stage IB non-small cell lung cancer (NSCLC) is still under debate considering the cost–benefit ratio between improvement in survival and side effects. We retrospectively evaluated survival and incidence of recurrence in radically...

Descripción completa

Detalles Bibliográficos
Autores principales: Casiraghi, Monica, Petrella, Francesco, Bardoni, Claudia, Mohamed, Shehab, Sedda, Giulia, Guarize, Juliana, Passaro, Antonio, De Marinis, Filippo, Maisonneuve, Patrick, Spaggiari, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004231/
https://www.ncbi.nlm.nih.gov/pubmed/36902867
http://dx.doi.org/10.3390/jcm12052081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004231/
https://www.ncbi.nlm.nih.gov/pubmed/36902867
http://dx.doi.org/10.3390/jcm12052081

Ejemplares similares